Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PetVivo Holdings, Inc. (PETV : OTC)

• Company Description    PetVivo Holdings Inc. is an emerging biomedical device company. It focused on the licensing and commercialization of medical devices and therapeutics for pets. PetVivo Holdings Inc. is based in MINNEAPOLIS, MN. Number of Employees: 24

• Price / Volume Information    Yesterday's Closing Price: $1.23 Daily Weekly Monthly 20 Day Moving Average: 21,969 shares Shares Outstanding: 33.58 (millions) Market Capitalization: $41.39 (millions) Beta: 1.25 52 Week High: $1.69 52 Week Low: $0.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.19% -5.79% 12 Week 49.45% 42.20% Year To Date 98.79% 72.04%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5151 Edina Industrial Blvd Suite 575 - Edina,MN 55439 USA ph: 952-405-6216 fax: - investors@petvivo.com http://www.petvivo.com

• General Corporate Information    Officers John Lai - Chief Executive Officer; President and Director Robert Rudelius - Chairman Garry Lowenthal - Chief Financial Officer Spencer Breithaupt - Director Diane Levitan - Director Peer Information PetVivo Holdings, Inc. (ABMD) PetVivo Holdings, Inc. (DMDS) PetVivo Holdings, Inc. (CPWY.) PetVivo Holdings, Inc. (EQUR) PetVivo Holdings, Inc. (ECIA) PetVivo Holdings, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 716817408 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 33.58 Most Recent Split Date: 9.00 (0.00:1) Beta: 1.25 Market Capitalization: $41.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 9.12 Price/Cash Flow: - Price / Sales: 31.67 EPS Growth vs. Year Ago Period: 18.18% vs. Previous Quarter: 18.18% Sales Growth vs. Year Ago Period: 140.32% vs. Previous Quarter: 32.44% ROE 09/30/25 - - 06/30/25 - -453.45 03/31/25 - -707.45 ROA 09/30/25 - - 06/30/25 - -153.82 03/31/25 - -181.34 Current Ratio 09/30/25 - - 06/30/25 - 1.41 03/31/25 - 1.30 Quick Ratio 09/30/25 - - 06/30/25 - 1.24 03/31/25 - 1.22 Operating Margin 09/30/25 - - 06/30/25 - -662.82 03/31/25 - -741.31 Net Margin 09/30/25 - - 06/30/25 - -662.89 03/31/25 - -741.40 Pre-Tax Margin 09/30/25 - - 06/30/25 - -662.82 03/31/25 - -741.31 Book Value 09/30/25 - - 06/30/25 - 0.14 03/31/25 - 0.17 Inventory Turnover 09/30/25 - - 06/30/25 - 0.60 03/31/25 - 0.38 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.09 03/31/25 - 0.13

Powered by Zacks Investment Research ©